Context Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Context Therapeutics Total Assets Growth & History (CNTX)
Context Therapeutics's total assets was $68.5M for fiscal 2025.
View full Context Therapeutics company overviewContext Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $68.5M | −$29.6M | −30.20% |
| 2024 | 2024-12-31 | $98.1M | $82.1M | +510.90% |
| 2023 | 2023-12-31 | $16.1M | −$21.9M | −57.69% |
| 2022 | 2022-12-31 | $38.0M | −$13.3M | −26.00% |
| 2021 | 2021-12-31 | $51.3M | $50.8M | +10878.25% |
| 2020 | 2020-12-31 | $467,340 | — | — |
Context Therapeutics quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $46.1M | −$41.0M | −47.06% |
| Q1 2026 | 2026-03-31 | $58.9M | −$34.1M | −36.69% |
| Q4 2025 | 2025-12-31 | $68.5M | −$29.6M | −30.20% |
| Q3 2025 | 2025-09-30 | $79.2M | −$7.1M | −8.22% |
| Q2 2025 | 2025-06-30 | $87.2M | −$15.6M | −15.15% |
| Q1 2025 | 2025-03-31 | $93.0M | $81.9M | +741.19% |
| Q4 2024 | 2024-12-31 | $98.1M | $82.1M | +510.90% |
| Q3 2024 | 2024-09-30 | $86.3M | $63.3M | +275.53% |
| Q2 2024 | 2024-06-30 | $102.7M | $74.9M | +269.96% |
| Q1 2024 | 2024-03-31 | $11.1M | −$20.9M | −65.43% |
| Q4 2023 | 2023-12-31 | $16.1M | −$21.9M | −57.69% |
| Q3 2023 | 2023-09-30 | $23.0M | −$19.1M | −45.37% |
| Q2 2023 | 2023-06-30 | $27.8M | −$16.9M | −37.89% |
| Q1 2023 | 2023-03-31 | $32.0M | −$15.1M | −32.03% |
| Q4 2022 | 2022-12-31 | $38.0M | −$13.3M | −26.00% |
| Q3 2022 | 2022-09-30 | $42.1M | $39.8M | +1762.65% |
| Q2 2022 | 2022-06-30 | $44.7M | — | — |
| Q1 2022 | 2022-03-31 | $47.0M | — | — |
| Q4 2021 | 2021-12-31 | $51.3M | $50.8M | +10878.25% |
| Q3 2021 | 2021-09-30 | $2.3M | — | — |
| Q4 2020 | 2020-12-31 | $467,340 | — | — |
Context Therapeutics total assets trends
Over the last five fiscal years, Context Therapeutics's total assets increased from $467,340 to $68.5M, a change of $68.0M. The latest reported quarter, Q2 2026, shows $46.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Context Therapeutics source filings ↗